Genomics of Drug Sensitivity in Cancer |
AR-42
|
Synonyms |
HDAC-42, AR 42, AR42
|
Targets |
HDAC1
|
Target pathway |
Chromatin histone acetylation
|
PubCHEM ID |
6918848
|
Jsmol |
|
Download molecule |
6918848
|
PUBCHEM IUPAC INCHI |
InChI=1S/C18H20N2O3/c1-12(2)16(13-6-4-3-5-7-13)18(22)19-15-10-8-14(9-11-15)17(21)20-23/h3-12,16,23H,1-2H3,(H,19,22)(H,20,21)/t16-/m0/s1
|
Smiles |
O=C(NO)C2(=CC=C(NC(=O)C(C1(=CC=CC=C1))C(C)C)C=C2)
|
Cluster number |
104
|
calculated LogS |
-4,179
|
Molecular weight |
312,368
|
calculated LogP |
2,8761
|
H-Acceptors |
5
|
H-Donors |
3
|
Ro5 violations |
0
|
Druglikeness |
1,9703
|
DrugScore |
0,344196711080696
|
Mutagenic |
high
|
Tumorigenic |
none
|
Reproductive Effective |
low
|
Irritant |
none
|
Fish Toxicity |
High FHMT
|
Fish Toxicity2 |
1,3565
|
Rat Acute Toxicity |
2,1686
|
Acute Oral Toxicity |
III
|
Caco-2 Permeability |
Caco2+
|
Caco-2 Permeability2 |
1,1223
|
P-glycoprotein Substrate |
Non-substrate
|
P-glycoprotein Inhibitor |
Non-inhibitor
|
P-glycoprotein Inhibitor2 |
Non-inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
Human Ether-a-go-go-Related Gene Inhibition2 |
Non-inhibitor
|
Tetrahymena Pyriformis Toxicity |
High TPT
|
Tetrahymena Pyriformis Toxicity2 |
1,0426
|
AMES Toxicity |
AMES toxic
|
CYP450 2C9 Substrate |
Non-substrate
|
CYP450 3A4 Substrate |
Non-substrate
|
CYP450 3A4 Inhibitor |
Non-inhibitor
|
CYP450 2C19 Inhibitor |
Non-inhibitor
|
CYP450 2C9 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Inhibitor |
Non-inhibitor
|
CYP450 1A2 Inhibitor |
Non-inhibitor
|
CYP450 2D6 Substrate |
Non-substrate
|
Biodegradation |
Not ready biodegradable
|
Carcinogenicity (Three-class) |
Carcinogens
|
Carcinogens |
Danger
|
Blood-Brain Barrier |
BBB+
|
CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
Honey Bee Toxicity |
Low HBT
|
Renal Organic Cation Transporter |
Non-inhibitor
|
Subcellular localization |
Mitochondria
|
Human Intestinal Absorption |
HIA+
|
Aqueous solubility |
-3,0588
|